152 related articles for article (PubMed ID: 2681438)
1. Prophylaxis of Pneumocystis carinii pneumonia: an update.
Kovacs JA; Masur H
J Infect Dis; 1989 Nov; 160(5):882-6. PubMed ID: 2681438
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
Kovacs JA; Masur H
Clin Infect Dis; 1992 May; 14(5):1005-9. PubMed ID: 1350925
[TBL] [Abstract][Full Text] [Related]
3. Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. The Swiss HIV Cohort Study.
Heald A; Flepp M; Chave JP; Malinverni R; Rüttimann S; Gabriel V; Renold C; Sugar A; Hirschel B
Ann Intern Med; 1991 Nov; 115(10):760-3. PubMed ID: 1929023
[TBL] [Abstract][Full Text] [Related]
4. [Preventive pentamidine inhalation of Pneumocystis carinii pneumonia in patients with immune deficiency. Preliminary evaluation of a multicenter study].
Schrappe-Bächer M; Fätkenheuer G; Salzberger B; Zehrer I; Bendick C; Rasokat H
Med Klin (Munich); 1990 Apr; 85 Suppl 2():276-80. PubMed ID: 2197537
[TBL] [Abstract][Full Text] [Related]
5. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
[TBL] [Abstract][Full Text] [Related]
6. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
7. The effects of long term zidovudine therapy and Pneumocystis carinii prophylaxis on HIV disease. A review of the literature.
Hoover DR
Drugs; 1995 Jan; 49(1):20-36. PubMed ID: 7705214
[TBL] [Abstract][Full Text] [Related]
8. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
[TBL] [Abstract][Full Text] [Related]
9. [Prospective study of primary and secondary prevention of Pneumocystis carinii pneumonia with pentamidine aerosol].
Staszewski S; Trinder S; Gottstein A; Odewald J; Rehmet S; Brodt R; Jacobi V; Müller R; Müller H; Helm EB
Med Klin (Munich); 1990 Apr; 85 Suppl 2():271-5. PubMed ID: 2374530
[TBL] [Abstract][Full Text] [Related]
10. [AIDS: prevention of pulmonary complications. Pneumocystis carinii pneumonia--mycobacterial infections].
Ullrich M
Fortschr Med; 1990 Feb; 108(4):23, 26. PubMed ID: 2312028
[No Abstract] [Full Text] [Related]
11. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus.
Centers for Disease Control (CDC)
MMWR Suppl; 1989 Jun; 38(5):1-9. PubMed ID: 2524643
[TBL] [Abstract][Full Text] [Related]
12. Prevention of lung infections associated with human immunodeficiency virus infection.
Hopewell PC
Thorax; 1989 Dec; 44(12):1038-44. PubMed ID: 2575801
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis against Pneumocystis carinii pneumonia in children infected with HIV.
Principi N; Marchisio P; Plebani A; Giaquinto C; Picco P
Lancet; 1991 May; 337(8750):1163. PubMed ID: 1674037
[No Abstract] [Full Text] [Related]
14. The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia.
Mohle-Boetani J; Akula SK; Holodniy M; Katzenstein D; Garcia G
West J Med; 1992 Mar; 156(3):303-6. PubMed ID: 1595261
[No Abstract] [Full Text] [Related]
15. [Impact of zidovudine treatment and the pneumocystis carinii prophylaxis in natural history of patients with HIV infection].
Sáiz Hervas E; Castilla Castellano V; Miquel Plaza J; Benito Blanco AM; Martín Llorens MM; Pastor de Blas M; Izquierdo P; Muñoz Jareño MA; Sierra A; Nieto MA; Moreno Collado AM; Fraguas C
An Med Interna; 1998 Mar; 15(3):132-7. PubMed ID: 9580410
[TBL] [Abstract][Full Text] [Related]
16. [Ambulatory therapy and prevention of the most frequent HIV-associated opportunistic infections].
Malinverni R; Blatter M
Schweiz Med Wochenschr; 1991 Aug; 121(34):1194-204. PubMed ID: 1925448
[TBL] [Abstract][Full Text] [Related]
17. Primary dapsone chemoprophylaxis for Pneumocystis carinii pneumonia in immunocompromised patients infected with the human immunodeficiency virus.
Lucas CR; Sandland AM; Mijch A; Simpson JM
Med J Aust; 1989 Jul; 151(1):30-3. PubMed ID: 2528052
[TBL] [Abstract][Full Text] [Related]
18. [Pneumocystis carinii pneumonia and AIDS].
Szabados A; Boroń-Kaczmarska A; Boroń P
Pol Tyg Lek; 1989 Apr; 44(17):379-81. PubMed ID: 2626357
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of AIDS-related opportunistic infections (OIs).
Hardy WD
AIDS Clin Rev; 1989; ():125-50. PubMed ID: 2562216
[No Abstract] [Full Text] [Related]
20. Prophylaxis of AIDS-related opportunistic infections (OIs). Current status and future strategies.
Hardy WD
AIDS Clin Rev; 1991; ():145-80. PubMed ID: 1651099
[No Abstract] [Full Text] [Related]
[Next] [New Search]
